U.S. Markets open in 1 hr, 21 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,226.94 | 203.52 | 2.03% |
| NASDAQ | 2,154.06 | 41.62 | 1.97% |
| S&P 500 | 1,093.08 | 23.78 | 2.22% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| EPS (TTM): | -1.03 | Current P/E Ratio: | -1.5534 |
|---|---|---|---|
| Last Quarter's Earnings: | -0.21 | Current Quarter Estimate: | -0.161 |
| Last Fiscal Year Earnings: | -1.02 | Next Fiscal Year Estimate: | -0.641 |
| Analyst Consensus: | Buy | Dividend Rate: | 0.00 |
| Last Dividend: | 0.00 |
First Call Consensus Recommendation Buy
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 01/11/2010 | 21:00 | ARIAD Pharmaceuticals, Inc. at JPMorgan Healthcare Conference |  |
| 11/18/2009 | 18:00 | ARIAD Pharmaceuticals, Inc. at Windhover Information Therapeutic Area Partnerships Conference | |
| 11/17/2009 | 18:00 | ARIAD Pharmaceuticals, Inc. at Lazard Capital Healthcare Conference | |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/05/2009 | Q3 2009 ARIAD Pharmaceuticals, Inc. Earnings Release | — | — |
| 11/05/2009 | Q3 2009 ARIAD Pharmaceuticals, Inc. Earnings Conference Call |  |
Download($) |
| 11/03/2009 | ARIAD Pharmaceuticals, Inc. at Oppenheimer & Co. Healthcare Conference | — | — |
| 09/09/2009 | ARIAD Pharmaceuticals, Inc. at Rodman & Renshaw Annual Global Investment Conference | |
— |
| 07/30/2009 | Q2 2009 ARIAD Pharmaceuticals, Inc. Earnings Conference Call | |
Download($) |
| 07/30/2009 | Q2 2009 ARIAD Pharmaceuticals, Inc. Earnings Release | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts